For medical professionals
Our ketamine treatment is for patients who have not adequately responded to three pharmacological treatment steps with antidepressants or have experienced too many side effects. Additionally, the patient must have a therapist with whom we can consult to ensure screening and continuity of care.
The program we offer is based on accepted scientifically validated protocols and is complementary to existing treatment. A referral from a treating therapist is necessary, with whom we engage in easy communication, keeping them informed of progress.
We use racemic (S/R) ketamine, administered intramuscularly. Racemic ketamine induces a powerful dynamic flow and stimulates the processes of surrender, release, and healing.
The patient is responsible for covering the costs of the ketamine program since we have no contracts with health insurers, which may consider the treatment as uninsured care. The costs for the complete ketamine program (3 screening moments, 6 ketamine treatments, and 10 therapeutic sessions) are based on the established rates of the Dutch Healthcare Authority and amount to €7,127.33.

